Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.

Autor: Metz R; New Link Genetics Corporation, Ames, IA, USA., Smith C; Lankenau Institute for Medical Research, Wynnewood, PA, USA., DuHadaway JB; Lankenau Institute for Medical Research, Wynnewood, PA, USA., Chandler P; Immunotherapy Center, Georgia Regents University, Augusta, GA, USA., Baban B; Immunotherapy Center, Georgia Regents University, Augusta, GA, USA., Merlo LMF; Lankenau Institute for Medical Research, Wynnewood, PA, USA., Pigott E; Lankenau Institute for Medical Research, Wynnewood, PA, USA., Keough MP; Lankenau Institute for Medical Research, Wynnewood, PA, USA., Rust S; New Link Genetics Corporation, Ames, IA, USA., Mellor AL; Immunotherapy Center, Georgia Regents University, Augusta, GA, USA., Mandik-Nayak L; Lankenau Institute for Medical Research, Wynnewood, PA, USA.; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, USA., Muller AJ; Lankenau Institute for Medical Research, Wynnewood, PA, USA.; Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Prendergast GC; Lankenau Institute for Medical Research, Wynnewood, PA, USA.; Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pathology, Anatomy and Cell Biology, Jefferson Medical School, Thomas Jefferson University, Philadelphia, PA, USA.

Publikováno v: International immunology [Int Immunol] 2019 Mar 05; Vol. 31 (3), pp. 181-182.

IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.

Autor: Metz R; New Link Genetics Corporation, Ames, IA 50010, USA., Smith C; Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA., DuHadaway JB; Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA., Chandler P; Immunotherapy Center, Georgia Regents University, Augusta, GA 30912, USA., Baban B; Immunotherapy Center, Georgia Regents University, Augusta, GA 30912, USA., Merlo LM; Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA., Pigott E; Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA., Keough MP; Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA., Rust S; New Link Genetics Corporation, Ames, IA 50010, USA., Mellor AL; Immunotherapy Center, Georgia Regents University, Augusta, GA 30912, USA., Mandik-Nayak L; Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA., Muller AJ; Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA., Prendergast GC; Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA Department of Pathology, Anatomy and Cell Biology, Jefferson Medical School, Thomas Jefferson University, Philadelphia, PA 19107, USA prendergast@limr.org.

Publikováno v: International immunology [Int Immunol] 2014 Jul; Vol. 26 (7), pp. 357-67. Date of Electronic Publication: 2014 Jan 08.

Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment.

Autor: Hayes CS; Authors' Affiliations: Aminex Therapeutics, Inc., Kenmore, Washington., Shicora AC, Keough MP, Snook AE, Burns MR, Gilmour SK

Publikováno v: Cancer immunology research [Cancer Immunol Res] 2014 Mar; Vol. 2 (3), pp. 274-85. Date of Electronic Publication: 2013 Oct 07.

Identification of novel tumor antigens with patient-derived immune-selected antibodies.

Autor: Rodriguez-Pinto D; Center for Vascular Biology, EM028, Department of Cell Biology-MC3501, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06030-3501, USA., Sparkowski J, Keough MP, Phoenix KN, Vumbaca F, Han DK, Gundelfinger ED, Beesley P, Claffey KP

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2009 Feb; Vol. 58 (2), pp. 221-34. Date of Electronic Publication: 2008 Jun 21.